Agnes M Rimando Selected Research

pterostilbene

1/2018	AMPK activation by pterostilbene contributes to suppression of hepatic gluconeogenic gene expression and glucose production in H4IIE cells.
11/2017	Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.
1/2017	Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer.
1/2017	Pterostilbene-induced changes in gut microbiota composition in relation to obesity.
8/2016	Effects of pterostilbene in brown adipose tissue from obese rats.
4/2016	Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer.
9/2015	Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer.
8/2014	Pterostilbene, a dimethyl ether derivative of resveratrol, reduces fat accumulation in rats fed an obesogenic diet.
6/2013	Anxiolytic action of pterostilbene: involvement of hippocampal ERK phosphorylation.
1/2013	Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Agnes M Rimando Research Topics

Disease

20	Neoplasms (Cancer) 01/2018 - 06/2002
9	Prostatic Neoplasms (Prostate Cancer) 11/2017 - 03/2010
6	Colonic Neoplasms (Colon Cancer) 12/2010 - 01/2007
5	Body Weight (Weight, Body) 01/2017 - 01/2007
4	Neoplasm Metastasis (Metastasis) 11/2017 - 01/2013
4	Carcinogenesis 09/2012 - 01/2007
4	Inflammation (Inflammations) 02/2012 - 02/2008
3	Insulin Resistance 01/2017 - 10/2008
3	Obesity 01/2017 - 09/2012
3	Aberrant Crypt Foci 07/2010 - 01/2007
2	Hyperglycemia 01/2017 - 09/2012
2	Glioma (Gliomas) 05/2012 - 01/2009
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Cognitive Dysfunction 07/2014
1	Growth Disorders 07/2014
1	Anxiety Disorders (Anxiety Disorder) 06/2013
1	Adenocarcinoma 07/2010
1	Hemolysis 03/2010
1	Breast Neoplasms (Breast Cancer) 01/2009
1	Colitis 02/2008
1	Weight Loss (Weight Reduction) 05/2007

Drug/Important Bio-Agent (IBA)

17	pterostilbeneIBA 01/2018 - 06/2002
16	ResveratrolIBA 01/2018 - 06/2002
10	StilbenesIBA 11/2017 - 07/2004
7	Proteins (Proteins, Gene)FDA Link 11/2017 - 09/2010
4	CholesterolIBA 01/2018 - 10/2008
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018 - 09/2012
3	AntioxidantsIBA 01/2018 - 06/2002
3	MicroRNAs (MicroRNA)IBA 01/2017 - 08/2015
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 08/2015
3	Biological ProductsIBA 08/2015 - 10/2008
2	3,3',4,5'-tetrahydroxystilbeneIBA 01/2017 - 08/2013
2	Blood Glucose (Blood Sugar)IBA 01/2017 - 09/2012
2	CarbohydratesIBA 01/2017 - 09/2012
2	GlucosidasesIBA 01/2017 - 09/2012
2	PolyphenolsIBA 01/2017 - 08/2013
2	AndrogensIBA 01/2016 - 03/2010
2	LipidsIBA 07/2014 - 04/2010
2	CytokinesIBA 08/2013 - 07/2009
2	XenobioticsIBA 09/2012 - 08/2008
2	FlavonoidsIBA 05/2012 - 01/2009
2	LipopolysaccharidesIBA 02/2012 - 07/2009
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2012 - 07/2009
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2010 - 07/2010
2	AzoxymethaneIBA 07/2010 - 01/2007
1	Histone Deacetylase InhibitorsIBA 11/2017
1	Vorinostat FDA Link 11/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2017
1	Hormones (Hormone)IBA 11/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	Sucrose (Saccharose)IBA 01/2017
1	TensinsIBA 01/2017
1	Starch (Cornstarch)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Acarbose FDA LinkGeneric 01/2017
1	Androgen Receptors (Androgen Receptor)IBA 01/2016
1	Messenger RNA (mRNA)IBA 09/2015
1	ChromatinIBA 08/2015
1	CalciumIBA 07/2014
1	Nucleic AcidsIBA 07/2014
1	Pharmaceutical PreparationsIBA 06/2013
1	Co-Repressor ProteinsIBA 01/2013
1	Mi-2 Nucleosome Remodeling and Deacetylase ComplexIBA 01/2013
1	Nucleosomes (Nucleosome)IBA 01/2013
1	EnzymesIBA 09/2012
1	VaccinesIBA 05/2012
1	wogoninIBA 05/2012
1	NitritesIBA 02/2012
1	RetinoidsIBA 12/2010
1	ChalconesIBA 12/2010
1	Chalcone (Benzalacetophenone)IBA 12/2010
1	Cyclin-Dependent Kinase Inhibitor p27IBA 09/2010
1	NF-kappa B (NF-kB)IBA 07/2010
1	Cyclin D1IBA 07/2010
1	beta CateninIBA 07/2010
1	Bile Acids and Salts (Bile Acids)IBA 04/2010
1	Ethanol (Ethyl Alcohol)IBA 04/2010
1	microcrystalline celluloseIBA 04/2010
1	3,5-dihydroxy-4'-methoxystilbeneIBA 03/2010
1	Glutathione (Reduced Glutathione)IBA 03/2010
1	pinostilbeneIBA 03/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2009
1	EndotoxinsIBA 07/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2009
1	p38 Mitogen-Activated Protein KinasesIBA 07/2009
1	PhytochemicalsIBA 10/2008
1	Prostaglandins EIBA 02/2008
1	ChlorophyllIBA 05/2007
1	Glyphosate (Roundup)IBA 05/2007

Therapy/Procedure

1	Chemoprevention 08/2013
1	Immunotherapy 05/2012
1	Therapeutics 01/2009